XTX Topco Ltd Has $907,000 Stock Holdings in Inspire Medical Systems, Inc. $INSP

XTX Topco Ltd lifted its position in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 209.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,989 shares of the company’s stock after purchasing an additional 4,732 shares during the period. XTX Topco Ltd’s holdings in Inspire Medical Systems were worth $907,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Quarry LP boosted its position in Inspire Medical Systems by 2,127.3% during the 1st quarter. Quarry LP now owns 245 shares of the company’s stock worth $39,000 after buying an additional 234 shares during the period. Banque Transatlantique SA bought a new position in shares of Inspire Medical Systems during the first quarter valued at $46,000. Smartleaf Asset Management LLC lifted its holdings in shares of Inspire Medical Systems by 27.2% during the first quarter. Smartleaf Asset Management LLC now owns 454 shares of the company’s stock worth $71,000 after purchasing an additional 97 shares during the period. Farther Finance Advisors LLC grew its stake in shares of Inspire Medical Systems by 14.6% in the second quarter. Farther Finance Advisors LLC now owns 603 shares of the company’s stock worth $78,000 after purchasing an additional 77 shares during the last quarter. Finally, AlphaQuest LLC grew its stake in shares of Inspire Medical Systems by 248.5% in the first quarter. AlphaQuest LLC now owns 1,028 shares of the company’s stock worth $164,000 after purchasing an additional 733 shares during the last quarter. Institutional investors and hedge funds own 94.91% of the company’s stock.

Inspire Medical Systems Trading Down 1.9%

Shares of INSP stock opened at $124.90 on Monday. Inspire Medical Systems, Inc. has a 12 month low of $70.77 and a 12 month high of $216.01. The firm has a market capitalization of $3.63 billion, a PE ratio of 84.97, a price-to-earnings-growth ratio of 13.48 and a beta of 0.69. The firm has a fifty day simple moving average of $84.35 and a two-hundred day simple moving average of $104.93.

Inspire Medical Systems (NYSE:INSP) last released its quarterly earnings results on Monday, November 3rd. The company reported $0.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.53. The business had revenue of $224.50 million during the quarter, compared to the consensus estimate of $220.39 million. Inspire Medical Systems had a return on equity of 9.41% and a net margin of 5.05%.The company’s quarterly revenue was up 10.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.60 EPS. On average, equities analysts predict that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current fiscal year.

Inspire Medical Systems declared that its Board of Directors has authorized a stock repurchase plan on Monday, August 11th that authorizes the company to buyback $200.00 million in outstanding shares. This buyback authorization authorizes the company to repurchase up to 8.6% of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s management believes its shares are undervalued.

Analysts Set New Price Targets

Several research analysts have commented on the company. Lake Street Capital set a $150.00 target price on Inspire Medical Systems and gave the stock a “buy” rating in a report on Tuesday, August 5th. Zacks Research upgraded Inspire Medical Systems from a “strong sell” rating to a “hold” rating in a research report on Monday, October 27th. Stifel Nicolaus set a $110.00 price objective on Inspire Medical Systems and gave the stock a “buy” rating in a research note on Monday, November 24th. Wolfe Research raised shares of Inspire Medical Systems from a “peer perform” rating to an “outperform” rating and set a $180.00 target price for the company in a research report on Tuesday, November 25th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Inspire Medical Systems from $110.00 to $82.00 and set a “neutral” rating for the company in a report on Tuesday, November 4th. Ten analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $134.88.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.